MedTrace Logo

Asthma Intervention Research (AIR) Trial

NCT00214526 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2015-08-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate the effectiveness and safety of the Alair System for the treatment of asthma.

This will be a multicenter, randomized controlled study comparing the effects of treatment with the Alair System to standard drug therapy. One-hundred and ten subjects will be randomized 1:1 to either the Alair Group (Medical management + Alair treatment),or Control Group (Medical management only).

Conditions

Interventions

PROCEDURE

Bronchial thermoplasty with the Alair System

Conventional therapy with ICS+LABA plus bronchial thermoplasty with the Alair System.

DRUG

Conventional therapy with ICS+LABA

Conventional therapy with ICS+LABA.

Sponsors & Collaborators

  • Asthmatx, Inc.

    lead INDUSTRY

Principal Investigators

  • Narinder S Shargill, PhD · Asthmatx, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Primary Completion
2006-07-31
Completion
2006-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00214526 on ClinicalTrials.gov